Accumulating evidence indicates that specific cognitive deficits may be present several years prior to an initial clinical diagnosis in individuals who later develop Alzheimer's disease (AD). In particular, recent research examining specific components of attentional control systems may be potential early cognitive markers for AD. For example, deficits in spatial controlled attention, working memory, and prospective memory have been shown in healthy middle-aged adults, who have the ApoE e-4 gene compared to individuals who do not have the e-4 allele, even though these individuals do not produce deficits on more standard neuropsychological measures. There have not been any studies that have attempted to decompose the hypothesized theoretical components of attentional processing (maintenance, selection, switching, and divided attention) presumed to be deficient in early stage AD. Moreover, there is little evidence that the underlying components of attention are consistent within an individual across different attentional measures and across different testing sessions. The goal of the present proposal is to target specific components of attention, and provide individual attentional profiles in an attempt to identify early cognitive markers for Alzheimer's Disease. In addition, recent evidence suggests that components of attention may be differentially affected by distinct personality types, and that variability in behavior may be an important discriminator in early stage DAT. Hence, the proposed studies will also provide indices of personality and variability profiles. The proposed experiments will isolate four distinct components of attention: maintenance, selection, switching, and divided attention. Based on the extant literature, three experiments will be designed to tap each of the four components of attention, yielding a battery of 12 attentional tests. Two categories of individuals will be tested in this battery: individuals who have a biologic parent with DAT and control individuals who do not have a biologic parent with DAT. Within each of these two categories, 3 age groups will be included (ages 45-54 years; 55-64 years; 65-74 years). Approximately 120 subjects per category (40 per age group within each category) will be tested in the first wave of experiments. We anticipate that 70% of the total sample will be tested beginning in year four for a second wave. The goal of these multiple tests will be to provide a replication of the factor structure, and also to index the consistency of the within-subject profiles. Analyses will be conducted to determine the relation between the attentional, personality, and variability profiles of the individuals and the biomarkers from the remaining Projects, along with APOe4 status of the individuals.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG026276-02
Application #
7309952
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2006-07-01
Budget End
2007-06-30
Support Year
2
Fiscal Year
2006
Total Cost
$34,647
Indirect Cost
Name
Washington University
Department
Type
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Stout, Sarah H; Babulal, Ganesh M; Ma, Chunyu et al. (2018) Driving cessation over a 24-year period: Dementia severity and cerebrospinal fluid biomarkers. Alzheimers Dement 14:610-616
Roe, Catherine M; Babulal, Ganesh M; Stout, Sarah H et al. (2018) Using the A/T/N Framework to Examine Driving in Preclinical AD. Geriatrics (Basel) 3:
Day, Gregory S; Musiek, Erik S; Morris, John C (2018) Rapidly Progressive Dementia in the Outpatient Clinic: More Than Prions. Alzheimer Dis Assoc Disord 32:291-297
Chen, Jason A; Fears, Scott C; Jasinska, Anna J et al. (2018) Neurodegenerative disease biomarkers A?1-40, A?1-42, tau, and p-tau181 in the vervet monkey cerebrospinal fluid: Relation to normal aging, genetic influences, and cerebral amyloid angiopathy. Brain Behav 8:e00903
Besser, Lilah; Kukull, Walter; Knopman, David S et al. (2018) Version 3 of the National Alzheimer's Coordinating Center's Uniform Data Set. Alzheimer Dis Assoc Disord 32:351-358
Villeneuve, Sylvia; Vogel, Jacob W; Gonneaud, Julie et al. (2018) Proximity to Parental Symptom Onset and Amyloid-? Burden in Sporadic Alzheimer Disease. JAMA Neurol 75:608-619
Su, Yi; Flores, Shaney; Hornbeck, Russ C et al. (2018) Utilizing the Centiloid scale in cross-sectional and longitudinal PiB PET studies. Neuroimage Clin 19:406-416
Sato, Chihiro; Barthélemy, Nicolas R; Mawuenyega, Kwasi G et al. (2018) Tau Kinetics in Neurons and the Human Central Nervous System. Neuron 97:1284-1298.e7
Cruchaga, Carlos; Del-Aguila, Jorge L; Saef, Benjamin et al. (2018) Polygenic risk score of sporadic late-onset Alzheimer's disease reveals a shared architecture with the familial and early-onset forms. Alzheimers Dement 14:205-214
Pottier, Cyril; Zhou, Xiaolai; Perkerson 3rd, Ralph B et al. (2018) Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study. Lancet Neurol 17:548-558

Showing the most recent 10 out of 352 publications